EUVIMEDEUVIMED entdecken
Open Access

Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence

Hadeesha Piyadasa, Benjamin Oberlton, Mikaela Ribi, Ke Leow, Jolene S Ranek, Inna Averbukh, Meelad Amouzgar, Candace C Liu, Davide G Franchina, Noah F Greenwald, Erin F McCaffrey, Rashmi Kumar und 28 weitere

Cancer Cell · 2026-01 · 44 (1) · 112-128.e6

DOI: 10.1016/j.ccell.2025.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-01. Verfasst von Hadeesha Piyadasa und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Glioma, Neoplasm Recurrence, Local, Brain Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas are among the most lethal cancers, with limited treatment options. To uncover hallmarks of therapeutic escape and tumor microenvironment (TME) landscape, we applied spatial proteomics, transcriptomics, and glycomics to 670 lesions from 310 adult and pediatric patients. Single-cell analysis shows high B7H3+ tumor cell prevalence in glioblastoma (GBM) and pleomorphic xanthoastrocytoma, while most gliomas, including pediatric cases, express targetable tumor antigens in less than 50% of tumor cells, potentially explaining trial failures. Paired samples of isocitrate dehydrogenase (IDH)-mutant gliomas reveal recurrence driven by tumor-immune spatial reorganization, shifting from T cell and vasculature-associated myeloid cell-enriched niches to microglia and CD206+ macrophage-dominated tumors. Multi-omic integration identified N-glycosylation as the best classifier of grade, while the immune transcriptome best predicted GBM survival. Provided as a community resource, this study offers a framework for glioma targeting, classification, outcome prediction, and a baseline of TME composition across all stages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaNeoplasm Recurrence, LocalBrain NeoplasmsHumansTumor MicroenvironmentAdultIsocitrate DehydrogenaseChildTranscriptomeProteomicsFemaleMaleSingle-Cell AnalysisGlycomicsMutationMiddle AgedGlioblastomaGene Expression ProfilingBiomarkers, TumorMultiomics

Stichwörter der Autor:innen

GBMTMEdiffuse midline gliomagliomaimmune regulationimmunotherapysingle-cell profilingspatial N-glycomespatial multi-omicstumor antigens

Substanzen

Isocitrate DehydrogenaseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Immunology Program, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Department of Chemistry and Sarafan ChEM-H, Stanford University, Stanford, CA, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Cancer Biology Program, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
  • Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • National Institutes of Health

Zitieren

APA

Piyadasa, H., Oberlton, B., Ribi, M., Leow, K., Ranek, J. S., Averbukh, I., Amouzgar, M., Liu, C. C., Franchina, D. G., Greenwald, N. F., McCaffrey, E. F., Kumar, R., Ferrian, S., Tsai, A. G., Filiz, F., Fullaway, C. C., Bosse, M., Varra, S. R., Kong, A., …, & Angelo, M. (2026). Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence. Cancer Cell, 44(1), 112-128.e6. https://doi.org/10.1016/j.ccell.2025.11.006

Vancouver

Piyadasa H, Oberlton B, Ribi M, Leow K, Ranek JS, Averbukh I, et al. Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence. Cancer Cell. 2026;44(1):112-128.e6. doi:10.1016/j.ccell.2025.11.006

BibTeX
@article{Piyadasa2026,
  author = {Piyadasa, Hadeesha and Oberlton, Benjamin and Ribi, Mikaela and Leow, Ke and Ranek, Jolene S and Averbukh, Inna and Amouzgar, Meelad and Liu, Candace C and Franchina, Davide G and Greenwald, Noah F and McCaffrey, Erin F and Kumar, Rashmi and Ferrian, Selena and Tsai, Albert G and Filiz, Ferda and Fullaway, Christine Camacho and Bosse, Marc and Varra, Sricharan Reddy and Kong, Alex and Sowers, Cameron and Gephart, Melanie Hayden and Nuñez-Perez, Pablo and Yang, EnJun and Travers, Mike and Schachter, Michael J and Liang, Samantha and Santi, Maria R and Bucktrout, Samantha and Gherardini, Pier Federico and Connolly, John and Cole, Kristina and Barish, Michael E and Brown, Christine E and Oldridge, Derek A and Drake, Richard R and Phillips, Joanna J and Okada, Hideho and Prins, Robert and Bendall, Sean C and Angelo, Michael},
  title = {Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {1},
  pages = {112--128.e6},
  doi = {10.1016/j.ccell.2025.11.006}
}
Kostenlos starten →